Urvi Das Sharma
Global Value Strategy and Payer Engagement Manager
Bangalore,KA
Summary
Skilled pharmacy graduate with a master's in analytical chemistry. Strong background in Pharmaceutical R&D, Medical Writing, and Market Access. Over 3 years of experience in Market Access within the diabetes sector, focusing on insulin and GLP-1 products across pipeline, in-market, and late-stage assets.
Overview
5
5
years of professional experience
6
6
years of post-secondary education
Work History
Global Value Strategy and Payer Engagement (VSPE) Manager
Novo Nordisk
2024.01 - Current
- VSPE Lead for Zegalogue: Ensuring launch readiness of Zegalogue at an affordable price point, to patients across key markets in light of GlucaGen Hypo-kit discontinuation.
- Market Access for In-market Semaglutide in T2D:
i. Development of payer engagement strategies and value tools for FLOW (CKD) and STRIDE (PAD) trials for Ozempic.
ii. Payer Value Tools for SOUL (CVD) for Ryvelsus.
iii. Reinforcing the value of semaglutide in type 2 diabetes.
- Market Access for Pipeline Semaglutide in T2D:
Leading CagriSema's early value proposition, based on subpopulation segmenting for optimal access. Understanding access criteria for premium reimbursable subpopulations. Positioning the value of weight loss in T2D as a key value driver for CagriSema.
- Market access for daily insulins: Regular updates of value tools to sustain daily insulin access.
Senior Associate Value Strategy and Payer Engagement (VSPE) Manager
Novo Nordisk
2022.08 - 2024.01
- Life Cycle Management of Xultophy and Ryzodeg from Global Market Access: Risk grid analysis, budget management, shaping of the Brand Plan, and updating value communication tools to support affiliates in NGI sustenance.
- Early gap analysis for Zegalogue: Development of early access strategy, launch market decisions, key competitor insight analysis, and determination of gap analysis in the Zealand Pharma asset handover.
Junior Associate Scientific Writer
Indegene Pvt. Ltd.
2020.03 - 2022.07
- Multichannel engagement strategy development to support promotional and non-promotional commercial tools in the field of oncology, vaccines, and biosimilars; developing educational materials for HCPs, patients, and key KOLs.
Education
Masters in Pharmacy - Analytical Chemistry
Manipal Academy of Higher Education
Manipal, India 2018.01 - 2020.01
Bachelors in Pharmacy - Pharmacy
Dr.B.C.Roy College of Pharmacy And Applied Health Sciences
Kolkata 2014.01 - 2018.01
Skills
- Strategic thinking
- Effective communication
- Stakeholder Engagement/Vendor Management
- Project Management
- Insights analysis
Awards
- NN Value Award, 11/01/23, Awarded for building and maintaining good relations with our key stakeholders and never compromising on quality and business ethics.
- Make it happen, 2022, Awarded for developing new content strategy for pediatric vaccine brand of Pfizer in region Gulf for their new campaign.
Publications
HPLC Method Development and Validation for Residue Analysis of Steroid:
https://rjptonline.org/AbstractView.aspx?PID=2023-16-12-81
Timeline
Global Value Strategy and Payer Engagement (VSPE) Manager
Novo Nordisk
2024.01 - Current
Senior Associate Value Strategy and Payer Engagement (VSPE) Manager
Novo Nordisk
2022.08 - 2024.01
Junior Associate Scientific Writer
Indegene Pvt. Ltd.
2020.03 - 2022.07
Masters in Pharmacy - Analytical Chemistry
Manipal Academy of Higher Education
2018.01 - 2020.01
Bachelors in Pharmacy - Pharmacy
Dr.B.C.Roy College of Pharmacy And Applied Health Sciences
2014.01 - 2018.01